The Phoenix Lab
How a Biotech's Collapse Fueled a Bioengineering Revolution
Article Navigation
When pharmaceutical giant Merck Serono shuttered its Geneva headquarters in 2012, it left behind more than empty laboratories—it left a scientific void. The closure eliminated 1,250 research jobs and marked the failure to integrate Serono's legacy after its 2007 acquisition by Merck KGaA. As Stefan Oschmann, Merck's executive board member, cited "pricing pressures, patent expiries, and falling productivity," Switzerland's biotech landscape seemed permanently scarred 3 . Yet from these ashes rose an unexpected phoenix: Harvard's Wyss Institute for Biologically Inspired Engineering. This is the story of how a vacant pharmaceutical shell became the birthplace of technologies poised to redefine medicine, sustainability, and materials science.
The Backstory: Merck Serono's Collapse and an Unexpected Opportunity
Merck KGaA's 2012 decision wasn't merely a corporate downsizing—it was a strategic implosion. The closure stemmed from duplicated European headquarters in Darmstadt and Geneva, suspended development of key drugs like multiple sclerosis treatment Movectro, and an inability to leverage Serono's innovative legacy. Only 750 staff were offered relocation, leaving state-of-the-art labs dormant 3 . This exit wasn't isolated; it reflected a broader trend of pharmaceutical retreats from basic research, prioritizing short-term profits over long-term discovery 3 .
Meanwhile, 3,600 miles away in Boston, the Wyss Institute was bursting at the seams. Founded in 2009 by bioengineer and visionary Dr. Don Ingber, Wyss had rapidly outgrown its original Harvard Square footprint. Its mission—"biologically inspired engineering"—demanded interdisciplinary spaces where biologists, engineers, and clinicians could collaborate on technologies mimicking nature's efficiency. The Institute's early breakthroughs included Organ Chips (microfluidic devices mimicking human organs) and shrilk (a plastic alternative inspired by insect shells), but physical constraints limited scalability 6 8 .
The solution emerged from crisis. In 2013, Wyss announced it would repurpose Merck Serono's abandoned Massachusetts facility into a new innovation hub. This wasn't just real estate arbitrage—it was a symbolic passing of the torch from traditional pharma to a nimble, translational research model 2 .
Wyss's Vision: Where Biology Meets Engineering
The Wyss Institute operates on a radical premise: Nature is the ultimate engineer. By decoding biological designs—whether in chiton mollusk shells, insect exoskeletons, or human tissues—researchers could solve medical and environmental challenges. Key focus areas included:
Molecular Robotics
Creating nanodevices for targeted drug delivery
Synthetic Biology
Engineering microbes to produce therapeutics or degrade pollutants
Human Organ Chips
Replacing animal testing with microchips mimicking lung, liver, or brain function
The Institute's "Wyss Effect" philosophy emphasized rapid translation: discoveries shouldn't languish in labs but advance to clinics, markets, and patients. This required a new kind of workspace—one Merck's shell could uniquely provide 1 .
The Transformation: From Pharma Labyrinth to Innovation Ecosystem
Merck's facility offered 110,000 square feet of specialized labs, but retrofitting it demanded visionary redesign:
Open Layouts
Walls gave way to collision-encouraging spaces where materials scientists could brainstorm with immunologists.
Maker Spaces
Machine shops (staffed by experts like John Caramanica) were placed centrally, enabling rapid prototyping of surgical devices or Organ Chip molds 7 .
BSL-3/4 Suites
High-containment labs allowed work on pathogens like SARS-CoV-2, critical for projects like OMNIVAX, a broad-spectrum vaccine platform 4 .
Living Walls
Incorporating plants and natural light reflected Wyss's commitment to biomimicry and researcher well-being.
The redesign turned Merck's hierarchical "silos" into a dynamic ecosystem mirroring natural networks—proving that architecture shapes innovation 1 7 .
Case Study: The Chiton Eye—Decoding Nature's Multifunctional Masterpiece
To grasp Wyss's approach, consider their landmark study of the chiton mollusk, Acanthopleura granulata. This sea creature's shell performs two seemingly incompatible functions: physical protection and vision. Unlike most eyes (made of organic proteins), the chiton's hundreds of eyes are inorganic, crafted from the same aragonite mineral as its armor 9 .
Methodology: Reverse-Engineering Evolution
A multidisciplinary team led by Dr. Joanna Aizenberg (Wyss) and Dr. Christine Ortiz (MIT) employed:
- High-Resolution Microscopy: Scanning electron microscopy (SEM) revealed nanostructural differences
- X-Ray Microtomography: 3D images mapped light pathways through aragonite crystals
- Crystallographic Analysis: X-ray diffraction compared crystal orientation
- Behavioral Assays: Testing chiton responses to moving shadows quantified visual acuity 9
| Feature | Protective Shell | Visual Lens |
|---|---|---|
| Mineral | Aragonite | Aragonite |
| Crystal Size | Small, irregular | Large, aligned |
| Organization | Disordered, dense | Gradient refractive index |
| Function | Impact resistance | Light focusing (~500 nm) |
Results and Analysis: The Trade-Off Principle
The team discovered that lens crystals were larger and aligned to focus light onto photoreceptive cells beneath. However, this optical optimization created mechanical vulnerabilities: eye regions were 30% weaker than surrounding armor. Nature compensated by:
Minimizing eye size
(0.1 mm diameter)
Embedding eyes within ridges
shielded by mineralized protrusions
Prioritizing vision zones
only in predator-detection areas
| Parameter | Protective Region | Eye Region | Functional Implication |
|---|---|---|---|
| Hardness (GPa) | 3.5 ± 0.4 | 2.1 ± 0.3 | Eyes more prone to damage |
| Transparency (%) | <10 | >85 | Critical for light transmission |
| Crystal Alignment | Random | Radial gradient | Focuses light effectively |
This research pioneered principles for multifunctional materials:
- Functional Compartmentalization: Isolate distinct tasks within substructures.
- Trade-off Management: Optimize one function while mitigating weaknesses.
- Self-Assembly: Use environmentally benign processes (e.g., mineral secretion).
These rules now guide Wyss projects from shrilk (insect-inspired bioplastic) to sensory-building materials 6 9 .
The Scientist's Toolkit: Essential Reagents for Bioinspired Innovation
Wyss's research leverages unconventional biological and synthetic reagents. Key examples include:
| Reagent | Source/Type | Function in Research | Application Example |
|---|---|---|---|
| Chitosan | Shrimp shells | Forms biodegradable polymer matrices | Shrilk bioplastic 6 |
| Fibroin | Silk protein | Enhances structural integrity in composites | Surgical foams, shrilk 6 |
| CO2/H2 Gas Mix | Industrial emissions | Feedstock for Circe microbes | Carbon-negative polymers 8 |
| RAGE Inhibitors | Synthetic small molecules | Block inflammation pathways | Azeliragon (COVID-19 therapy) |
| Aragonite | Marine mollusks | Model for multifunctional materials | Chiton-inspired sensors 9 |
Impact: From Empty Shells to Global Solutions
Since occupying Merck's former space, Wyss has accelerated breakthroughs across sectors:
Collaboration
- Annual retreats now convene 550+ scientists, investors, and industry leaders to tackle "Grand Challenges" like cancer and climate change 1 .
Conclusion: A Blueprint for Scientific Renaissance
The Wyss Institute's resurrection of Merck Serono's shell represents more than a real estate transaction—it's a paradigm shift. Where pharma saw disposable infrastructure, visionaries like Ingber saw an ecosystem for convergence science. By blending biology, engineering, and entrepreneurship in retooled labs, Wyss proves that collaborative environments breed world-changing innovation. As Ingber declared at the 2025 Wyss Retreat: "We are a community of creators—and we will not stop" 1 . In science's unending evolution, sometimes the most fertile ground is found amid the ashes of the old.